false
English
Catalog
Cased-Based Controversies in Locally Advanced NSCL ...
Case-based Controversies in Locally Advanced NSCLC ...
Case-based Controversies in Locally Advanced NSCLC: A Radiation Oncology Update - Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The ISLC webinar focused on controversies and updates in the treatment of locally advanced non-small cell lung cancer (NSCLC), particularly within radiation oncology. Moderated by Dr. Stephen Chun from MD Anderson Cancer Center, the webinar included presentations by Dr. Andrea Filippi and Dr. Pamela Sampson. Dr. Filippi discussed recent clinical trials, such as Pacific II and Checkmate 73L, which explored combining immunotherapy with chemotherapy in treating stage III NSCLC. These trials were negative, indicating that concurrent immunotherapy with chemoradiation may not be effective. Ongoing trials and molecular data updates highlight promising avenues and significant molecular responses. Dr. Sampson addressed the challenges of re-irradiation therapy in NSCLC for recurrent early-stage disease. She outlined decision-making frameworks, patient selection for re-treatment, and dosimetric considerations, emphasizing the growing need to incorporate advanced imaging and plan evaluation strategies to ensure safety. The presentations underscored the complexity of treating locally advanced NSCLC, reflecting advances in medical technology and emerging treatment modalities, such as targeted therapies and the integration of immunotherapy. Panelists also discussed pertinent case studies and addressed challenging scenarios like in-field recurrences and management options after perioperative therapies. The webinar offered education on current controversies and strategies that aim to better clinical outcomes, illustrating the dynamic and rapidly evolving landscape of lung cancer management.
Asset Subtitle
Recording
Keywords
locally advanced NSCLC
radiation oncology
immunotherapy
chemotherapy
clinical trials
re-irradiation therapy
molecular responses
targeted therapies
advanced imaging
lung cancer management
×
Please select your language
1
English
5
普通话
11
Dutch